Dow Up2.00% Nasdaq Up1.66%

ANI Pharmaceuticals, Inc. (ANIP)

-NasdaqGM
29.01 Up 0.54(1.90%) Feb 12, 3:59PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
Total Revenue 55,970   30,082   20,371  
Cost of Revenue11,473  9,974  9,167  
Gross Profit 44,497   20,108   11,204  
Operating Expenses
Research Development2,678  1,712  1,158  
Selling General and Administrative17,935  16,388  9,521  
Non Recurring -   -   -  
Others3,878  1,110  567  
Total Operating Expenses -   -   -  
Operating Income or Loss 20,006   898   (42)
Income from Continuing Operations
Total Other Income/Expenses Net160  (305)(241)
Earnings Before Interest And Taxes20,166  593  (283)
Interest Expense787  467  1,327  
Income Before Tax19,379  126  (1,610)
Income Tax Expense(9,368)20  (36)
Minority Interest -   -   -  
Net Income From Continuing Ops28,747  106  (1,574)
Non-recurring Events
Discontinued Operations -  195  68  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 28,747   301   (1,506)
Preferred Stock And Other Adjustments -  (4,975)(6,922)
Net Income Applicable To Common Shares 28,747   (4,869) (8,496)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.